Your browser doesn't support javascript.
loading
Patients infected with Mycobacterium africanum versus Mycobacterium tuberculosis possess distinct intestinal microbiota.
Namasivayam, Sivaranjani; Diarra, Bassirou; Diabate, Seydou; Sarro, Yeya Dit Sadio; Kone, Amadou; Kone, Bourahima; Tolofoudie, Mohamed; Baya, Bocar; Diakite, Mahamane T; Kodio, Ousmane; Cohen, Keira; Holl, Jane; Achenbach, Chad J; Chatterjee, Soumya; Murphy, Robert Leo; Bishai, William; Diallo, Souleymane; Sher, Alan; Maiga, Mamoudou.
Afiliação
  • Namasivayam S; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Diarra B; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Diabate S; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Sarro YDS; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Kone A; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Kone B; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Tolofoudie M; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Baya B; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Diakite MT; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Kodio O; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Cohen K; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Holl J; Northwestern University, Institute for Global Health, Chicago, Illinois, United States of America.
  • Achenbach CJ; Northwestern University, Institute for Global Health, Chicago, Illinois, United States of America.
  • Chatterjee S; Saint Louis University, Division of Infectious Diseases, Allergy & Immunology, Saint Louis, Missouri, United States of America.
  • Murphy RL; Northwestern University, Institute for Global Health, Chicago, Illinois, United States of America.
  • Bishai W; Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
  • Diallo S; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
  • Sher A; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Maiga M; University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
PLoS Negl Trop Dis ; 14(5): e0008230, 2020 05.
Article em En | MEDLINE | ID: mdl-32401750
ABSTRACT

BACKGROUND:

Mycobacterium tuberculosis complex (MTBC), the causative agent of tuberculosis (TB), is composed of eight subspecies. TB in West Africa, in contrast to other geographical regions, is caused by Mycobacterium africanum (MAF) in addition to M. tuberculosis (MTB), with both infections presenting similar symptoms. Nevertheless, MAF is considered to be hypovirulent in comparison with MTB and less likely to progress to active disease. In this study, we asked whether MAF and MTB infected patients possess distinct intestinal microbiomes and characterized how these microbiota communities are affected by anti-tuberculosis therapy (ATT). Additionally, we assessed if the changes in microbiota composition following infection correlate with pathogen induced alterations in host blood-gene expression.

METHODS:

A longitudinal, clinical study of MAF infected, MTB infected patients assessed at diagnosis and two months after start of ATT, and healthy, endemic controls was conducted to compare compositions of the fecal microbiome as determined by 16S rRNA sequencing. A blood transcriptome analysis was also performed on a subset of subjects in each group by microarray and the results cross-compared with the same individual's microbiota composition.

FINDINGS:

MAF participants have distinct microbiomes compared with MTB patients, displaying decreased diversity and increases in Enterobacteriaceae with respect to healthy participants not observed in the latter patient group. Interestingly, this observed elevation in Enterobacteriaceae positively correlated with enhanced inflammatory gene expression in peripheral blood and was reversed after initiation of ATT.

INTERPRETATION:

Our findings indicate that MAF and MTB have distinct associations with the gut microbiome that may be reflective of the differential susceptibility of West Africans to these two co-endemic infections either as biomarkers or as a contributing determinant.
Assuntos

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Bactérias / Tuberculose / Microbioma Gastrointestinal / Mycobacterium / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Negl Trop Dis Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Bactérias / Tuberculose / Microbioma Gastrointestinal / Mycobacterium / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Negl Trop Dis Ano de publicação: 2020 Tipo de documento: Article